- Filed
- May 15, 2019 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Cash And Equivalents | Q1 2019 · Mar 31, 2019 | $22.2M |
| Cash And Equivalents | Q1 2019 · Dec 31, 2018 | $22.47M |
| Current Liabilities | Q1 2019 · Mar 31, 2019 | $451.52M |
| Current Liabilities | Q1 2019 · Dec 31, 2018 | $447.87M |
| Total Liabilities | Q1 2019 · Mar 31, 2019 | $538.41M |
| Total Liabilities | Q1 2019 · Dec 31, 2018 | $523.69M |
| Current Assets | Q1 2019 · Mar 31, 2019 | $57.31M |
| Current Assets | Q1 2019 · Dec 31, 2018 | $61.5M |
| Total Assets | Q1 2019 · Mar 31, 2019 | $455.1M |
| Total Assets | Q1 2019 · Dec 31, 2018 | $444.31M |
| Capex | Q1 2019 · Mar 31, 2018 | $248K |
| Operating Cash Flow | Q1 2019 · Mar 31, 2018 | $4.19M |
| Stockholders Equity | Q1 2019 · Mar 31, 2018 | −$99.26M |
| Stockholders Equity | Q1 2019 · Dec 31, 2017 | −$95.91M |
| Eps Diluted | Q1 2019 · Mar 31, 2018 | −$0.46 |
| Eps Basic | Q1 2019 · Mar 31, 2018 | −$0.46 |
| Sga Expense restated | Q1 2019 · Mar 31, 2018 | $14.85M |
| Net Income | Q1 2019 · Mar 31, 2018 | −$3.37M |
| Operating Income | Q1 2019 · Mar 31, 2018 | $7.59M |
| Revenue | Q1 2019 · Mar 31, 2018 | $38.45M |